• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

C-Rad

37.40 SEK+1.08 %15.7, 17.25
Less than 1K followers

CRAD B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.08 %
+3.89 %
+38.52 %
+14.90 %
+17.06 %
+9.04 %
+34.05 %
-37.56 %
+188.03 %

C-Rad operates in the medical technology industry and focuses on the development and manufacture of systems for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The business is present on a global level, with a main presence in Europe, North America and Asia. C-Rad was founded in 2004 and is headquartered in Uppsala, Sweden.

Read more
Market cap
1.26B SEK
Turnover
419.31K SEK
Revenue
441.9M
EBIT %
10.21 %
P/E
120.65
Dividend yield-%
0.27 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
17.7
2026

Interim report Q2'26

22.10
2026

Interim report Q3'26

11.2
2027

Annual report '26

Regulatory press release15.05.2026, 09.00

C-RAD and SeeTreat partner to deliver personalised radiotherapy for every patient

C-Rad
Press release13.05.2026, 09.00

C-RAD marks its new chapter at ESTRO 2026 with clinician-driven SGRT advances

C-Rad
Regulatory press release06.05.2026, 08.00

C-RAD's Interim Report Q1’26

C-Rad

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release10.04.2026, 15.00

C-RAD publishes its annual report for 2025

C-Rad
C-RAD, Audiocast, Q4'25
Webcast12.02.2026, 11.00

C-RAD, Audiocast, Q4'25

C-Rad
Regulatory press release12.02.2026, 08.00

C-RAD's Year-end report Q4'25

C-Rad
Press release29.01.2026, 08.00

Invitation to presentation of C-RAD’s year-end report and report for the fourth quarter 2025

C-Rad
Regulatory press release26.01.2026, 14.25

Tomas Blomquist appointed new CEO of C-RAD

C-Rad
C-RAD, Audiocast, Q3'25
Webcast23.10.2025, 11.00

C-RAD, Audiocast, Q3'25

C-Rad
Regulatory press release22.10.2025, 17.55

C-RAD has decided to repurchase own class B shares

C-Rad
Regulatory press release21.10.2025, 19.00

C-RAD ABs Interim Report Q3 2025

C-Rad
Press release21.10.2025, 18.20

C-RAD advances approval of interim report for Q3 2025

C-Rad
Regulatory press release21.10.2025, 18.15

C-RAD's CEO leaves, CFO Linda Frölén appointed acting CEO, Johan Danielsson is appointed deputy CEO

C-Rad
Press release09.10.2025, 08.00

Invitation to presentation of C-RAD’s interim report and report for the third quarter 2025

C-Rad
Press release30.09.2025, 09.00

C-RAD Strengthens Czech Presence with a strategically important order from Krajská Nemocnice Hospital in Liberec.

C-Rad
Press release26.09.2025, 10.00

C-RAD showcases new developments at ASTRO 2025

C-Rad
Regulatory press release28.07.2025, 08.00

C-RAD and iRT Systems announce partnership to advance safety in radiotherapy

C-Rad
C-RAD, Audiocast, Q2'25
Webcast18.07.2025, 11.00

C-RAD, Audiocast, Q2'25

C-Rad
Regulatory press release18.07.2025, 08.00

C-RAD AB's Interim Report Q2 2025

C-Rad
Press release04.07.2025, 09.30

C-RAD Secures 8 MSEK Service Order with Leading U.S. East Coast Healthcare Provider

C-Rad